Cite

HARVARD Citation

    Zubiri, L. et al. (2020). Immune‐Related Adverse Events in the Setting of PD‐1/L1 Inhibitor Combination Therapy. Oncologist. pp. e398-e404. [Online]. 
  
Back to record